Who owns Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income?

Tip: Access positions for across all investors

Analyze quarterly positions in Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income stock

Who bought or sold Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Pacer Advisors 652k $603k 0% Dec 2023
 View chart
Highlander Capital Management 25k $23k 0% Dec 2023
 View chart